**Question:** Features of tumor lysis syndrome are-

A. Hyperuricemia
B. Hyperkalemia
C. Hypocalcemia
D. Hyperphosphatemia

**Core Concept:** Tumor lysis syndrome (TLS) is a potentially life-threatening complication that occurs when rapidly dividing cancer cells are destroyed by chemotherapy or radiation therapy. This leads to the release of cellular waste products, such as uric acid, potassium, calcium, and phosphate, into the bloodstream. These elevated levels can cause organ dysfunction and electrolyte imbalances.

**Why the Correct Answer is Right:**

Correct Answer: TLS is characterized by the rapid release of nucleotides, nucleosides, and ions from the rapidly dividing cancer cells, leading to the development of hyperuricemia (high uric acid levels), hyperkalemia (high potassium levels), hyperphosphatemia (high phosphate levels), and hypocalcemia (low calcium levels). These imbalances can cause organ dysfunction and electrolyte disturbances.

**Why Each Wrong Option is Incorrect:**

A. Hyperuricemia is a feature of TLS, but the correct answer should include all the features, not just uric acid.
B. Hyperkalemia is a correct feature of TLS, but the correct answer should include all the features, not just potassium levels.
C. Hypocalcemia is a correct feature of TLS, but the correct answer should include all the features, not just calcium levels.
D. Hyperphosphatemia is a correct feature of TLS, but the correct answer should include all the features, not just phosphate levels.

**Clinical Pearl:** Thoroughly assessing patients with rapidly growing tumors before starting chemotherapy or radiation therapy is crucial to prevent TLS. Monitoring electrolyte levels, uric acid, and renal function tests is essential in predicting and managing this complication. Prompt intervention with hydration, loop diuretics, and allopurinol can prevent severe complications and improve patient outcomes.